EGF Theramed Health Corp.
EVAHF
$0.07
-$0.01-12.50%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 99.23% | -18.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 99.23% | -18.33% | |||
| Operating Income | -99.23% | 18.33% | |||
| Income Before Tax | -2,761.88% | 66.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3,908.05% | 66.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -194.29% | -76.67% | |||
| Net Income | -4,202.67% | 65.73% | |||
| EBIT | -99.23% | 18.33% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -4,195.24% | 65.57% | |||
| Normalized Basic EPS | -3,220.00% | 64.29% | |||
| EPS Diluted | -4,195.24% | 65.57% | |||
| Normalized Diluted EPS | -3,220.00% | 64.29% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||